WASHINGTON INSTITUTE FOR COAGULATION

Washington Institute for Coagulation specializes in the manufacturing and supply of specialized blood-derived pharmaceutical products, with deep expertise in hemostatic agents, plasma fractionation, and therapeutic formulations for bleeding disorders. Their technical capabilities encompass GMP-compliant pharmaceutical preparation, cryoprecipitate processing, and the development of factor concentrates tailored for hemophilia and other coagulopathies. The organization demonstrates precision in handling sensitive biological materials under strict regulatory controls, ensuring product purity, stability, and batch-to-batch consistency critical for clinical use in trauma, surgical, and chronic care settings. Their focus on rare therapeutic proteins and blood product integrity distinguishes them as a niche supplier in the advanced biologics space. The contractor maintains a consistent and focused relationship with the Department of Veterans Affairs, delivering mission-critical blood products and targeted medications for veterans with coagulation disorders, including those resulting from combat injuries or chronic conditions. Their work supports VA’s specialized hematology and transfusion medicine programs, providing reliable, FDA-regulated therapeutics that align with VA clinical guidelines and inventory protocols. Their primary industry focus is pharmaceutical preparation manufacturing under NAICS 325412, where they operate at the intersection of biopharmaceutical production and transfusion medicine. They serve a highly specialized vertical within the federal healthcare market, addressing unmet needs in coagulation therapy with products that require stringent cold-chain logistics, sterility assurance, and traceability from plasma sourcing to final dosing. As an 8H-certified entity based in Seattle, Washington, Washington Institute for Coagulation operates as a small business with a targeted, mission-driven footprint in the federal biologics supply chain. While lacking formal government certifications beyond its entity structure, its consistent delivery of regulated blood products underscores its adherence to FDA and AABB standards. The organization is positioned as a dependable, specialized vendor within the VA’s network of coagulation therapy providers.